PROCERA BRIDGE ALUMINA
K053050 · Nobel Biocare AB · NHA · Feb 22, 2006 · Dental
Device Facts
| Record ID | K053050 |
| Device Name | PROCERA BRIDGE ALUMINA |
| Applicant | Nobel Biocare AB |
| Product Code | NHA · Dental |
| Decision Date | Feb 22, 2006 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 872.3630 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
Nobel Biocare's Procera® Bridge Alumina is indicated for use as the core structure of an artificial prosthesis for partially edentulous patients in the need of prosthetic oral reconstruction in order to restore chewing function. The Procera® Bridge Alumina may be two, three, or four units and is cemented to natural or artificial tooth abutments.
Device Story
Procera® Bridge Alumina is a prefabricated, precision-milled core structure for artificial dental prostheses. Fabricated from a single solid piece of densely sintered aluminum oxide (Alumina). Designed for partially edentulous patients to restore chewing function. Used in clinical dental settings; operated by dental professionals. The bridge is personalized to patient-specific dimensions to ensure precise fit and function. It is cemented or bonded to natural or artificial tooth abutments. Benefits include structural support for dental prosthetics and restoration of oral function.
Clinical Evidence
No clinical data provided. Substantial equivalence is based on bench testing and material properties.
Technological Characteristics
Material: Densely sintered aluminum oxide (Alumina). Form factor: Prefabricated, precision-milled bridge core (2-4 units). Energy source: None (mechanical device). Connectivity: None. Sterilization: Not specified.
Indications for Use
Indicated for partially edentulous patients requiring prosthetic oral reconstruction to restore chewing function. Used as a core structure for 2-4 unit artificial prostheses cemented to natural or artificial tooth abutments.
Regulatory Classification
Identification
An endosseous dental implant abutment is a premanufactured prosthetic component directly connected to the endosseous dental implant and is intended for use as an aid in prosthetic rehabilitation.
Special Controls
*Classification.* Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)
Predicate Devices
- Procera® Bridge Zirconia (K041283)
Related Devices
- K041283 — PROCERA BRIDGE ZIRCONIA · Nobel Biocare AB · May 28, 2004
- K053125 — PROCERA BRIDGE ZIRCONIA · Nobel Biocare AB · Feb 22, 2006
- K071182 — PROCERA BRIDGE ZIRCONIA 9 UNITS-14 UNITS, MODELS 30-4004 TO 30-4013 · Nobel Biocare AB · Jul 11, 2007
- K091907 — NOBELPROCERA IMPLANT BRIDGE ZIRCONIA · Nobel Biocare AB · Oct 6, 2009
- K032562 — PROCEARA COPINGS AND PONTIC · Nobel Biocare AB · Feb 6, 2004
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows a handwritten sequence of characters, which appears to be a combination of letters and numbers. The sequence reads 'K053050'. The characters are written in a bold, somewhat irregular style, giving them a distinct, hand-drawn appearance. The contrast between the characters and the background is high, making the sequence easily readable.
## 510(k) Summary of Safety and Effectiveness 1.4
| Submitted by: | Phuong Nguyen Son<br>Regulatory Affairs Specialist |
|----------------------------------------|----------------------------------------------------------------------------|
| Address: | Nobel Biocare USA LLC<br>22715 Savi Ranch Parkway<br>Yorba Linda, CA 92887 |
| Telephone: | (714) 282-4800, ext. 7830 |
| Facsimile: | (714) 282-9023 |
| Date of Submission: | October 26, 2005 |
| Classification Name: | Porcelain Tooth (21 CFR 872.3920) |
| Trade or Proprietary<br>or Model Name: | Procera® Bridge Alumina |
| Legally Marketed Device(s): | Procera® Bridge Zirconia (K041283) |
## Device Description:
Nobel Biocare's Procera® Bridge Alumina is a prefabricated device intended for use as the core structure of an artificial prosthesis for placement in the oral cavity in order to restore chewing function.
The Procera® Bridge Alumina may be two, three, or four units and is precision milled. The Procera Bridge Alumina can be cemented or bonded to either natural or artificial tooth abutments. It is personalized according to the specific dimensions of the patient's so the bridge precisely fits, and properly functions, in the patient's jaw.
Nobel Biocare's Procera® Bridge Alumina is manufactured from one solid piece of densely sintered aluminum oxide (Alumina).
## Indications for Use:
Nobel Biocare's Procera® Bridge Alumina is indicated for use as the core structure of an artificial prosthesis for partially edentulous patients in the need of prosthetic oral reconstruction in order to restore chewing function. The Procera® Bridge Alumina may be two, three, or four units and is cemented to natural or artificial tooth abutments.
{1}------------------------------------------------
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three heads, representing the department's mission to protect the health of all Americans and provide essential human services. The words "DEPARTMENT OF HEALTH AND HUMAN SERVICES, USA" are arranged in a circular pattern around the eagle.
## Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
FEB 2 2 2006
Nobel Biocare USA AB C/O Mr. Phuong Nguyen Son Regulatory Affairs Specialist Nobel Biocare USA LLC 22715 Savi Ranch Parkway Yorba Linda, California 92887
Re: K053050
Trade/Device Name: Procera Bridge Alumina Regulation Number: 872.3630 Regulation Name: Endosseous Dental Implant Abutment Regulatory Class: II Product Code: NHA Dated: February 10, 2006 Received: February 13, 2006
Dear Mr. Son:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device mendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general approvisions of the Act. The general controls provisions of the Act include econorements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Eederal Register.
{2}------------------------------------------------
Page 2 - Mr. Son
Please be advised that FDA's issuance of a substantial equivalence determination does not I Teast be advisod that 127 to testainst on that your device complies with other requirements modi that I Dri nas made waters and regulations administered by other Federal agencies. of the Act of any I outeral based is requirements, including, but not limited to: registration 1 ou indisting (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice allu listing (21 CFR rat 807), availity systems (QS) regulation (21 CFR Part 820); and if requirements as set form in the qualify ijon control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) This letter will and in J . The FDA finding of substantial equivalence of your device to a premarket notification. The PDF results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), If you desire specific at the not no no no at (240) 276-0115. Also, please note the regulation prease contact the Online reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the may obtain of Small Manufacturers, International and Consumer Assistance at its toll-frec number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Chih-Lin, Ph.D.
Chiu Lin, Ph.D. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{3}------------------------------------------------
KOS3050 510(k) Number (if known):
Device Name: Procera Bridge Alumina
Indications For Use:
Nobel Biocare's Procera Bridge Alumina is indicated for use as the core structure of an artificial prosthesis for partially edentulous patients in the need of prosthetic oral reconstruction in order to restore chewing function. The Procera Bridge Alumina may be two, three, or four units and is cemented to natural or artificial tooth abutments.
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Susa Quaser
technology, General Hosp.
and Dental Devices
K05 3050